The impact of metabolic diseases and their comorbidities for stroke in a middle-income area of China: a case-control study

References

• O’Donnell MJ, et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet. 2010;376(9735):112–23.
   PubMed Web of Science ®Google Scholar
• O’Donnell MJ, et al. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study. Lancet, 2016;388(10046):761–75.
   PubMed Web of Science ®Google Scholar
• Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1736–1788.
   PubMed Web of Science ®Google Scholar
• Wu S, et al. Stroke in China: advances and challenges in epidemiology, prevention, and management. Lancet Neurol. 2019;18(4):394–405.
   PubMed Web of Science ®Google Scholar
• Walker RW, et al. Stroke risk factors in an incident population in urban and rural Tanzania: a prospective, community-based, case-control study. Lancet Glob Health. 2013;1(5):e282-8.
   PubMedGoogle Scholar
• Wang, J, et al. Risk factors for stroke in the chinese population: a systematic review and meta-analysis. J Stroke Cerebrovasc Dis. 2017;26(3):509–517.
   PubMed Web of Science ®Google Scholar
• Peters SA, Huxley RR, Woodward M. Diabetes as a risk factor for stroke in women compared with men: a systematic review and meta-analysis of 64 cohorts, including 775,385 individuals and 12,539 strokes. Lancet. 2014;383(9933):1973–80.
   PubMed Web of Science ®Google Scholar
• Feigin VL, et al. Global burden of stroke and risk factors in 188 countries, during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet Neurol, 2016;15(9):913–924.
   PubMed Web of Science ®Google Scholar
• Li Y, et al. Burden of hypertension in China: A nationally representative survey of 174,621 adults. Int J Cardiol. 2017;227:516–523.
   PubMed Web of Science ®Google Scholar
• Li Y, et al. Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: national cross sectional study. BMJ. 2020;369:m997.
   PubMedGoogle Scholar
• Opoku S, et al. Prevalence and risk factors for dyslipidemia among adults in rural and urban China: findings from the China National Stroke Screening and prevention project (CNSSPP). BMC Public Health. 2019;19(1):1500.
   PubMedGoogle Scholar
• Zhang, Y, et al. Prehypertension, diabetes, and cardiovascular disease risk in a population-based sample: the Strong Heart Study. Hypertension. 2006;47(3):410–414.
   PubMed Web of Science ®Google Scholar
• Qiu, M, et al. Effects of prediabetes mellitus alone or plus hypertension on subsequent occurrence of cardiovascular disease and diabetes mellitus: longitudinal study. Hypertension. 2015;65(3):525–530.
   PubMedGoogle Scholar
• Michishita R, et al. Hypertension and hyperglycemia and the combination thereof enhances the incidence of chronic kidney disease (CKD) in middle-aged and older males. Clin Exp Hypertens. 2017;39(7):645–654.
   PubMed Web of Science ®Google Scholar
• Hashemi Madani N, et al. Impaired fasting glucose and major adverse cardiovascular events by hypertension and dyslipidemia status: the Golestan cohort study. BMC Cardiovasc Disord. 2020;20(1):113.
   PubMedGoogle Scholar
• Hatano S, Experience from a multicentre stroke register: a preliminary report. Bull World Health Organ. 1976;54(5):541–553.
   PubMed Web of Science ®Google Scholar
• Chinese guidelines on prevention and treatment of dyslipidemia in adults. Zhonghua Xin Xue Guan Bing Za Zhi, 2007;35(5):390–419.
   PubMedGoogle Scholar
• Owolabi MO, et al. Dominant modifiable risk factors for stroke in Ghana and Nigeria (SIREN): a case-control study. Lancet Glob Health. 2018;6(4):e436–e446.
   PubMedGoogle Scholar
• Anniwaer J, et al. Homocysteine might increase the risk of recurrence in patients presenting with primary cerebral infarction. Int J Neurosci. 2019;129(7):654–659.
   PubMed Web of Science ®Google Scholar
• Gruneir A, et al. Increasing comorbidity and health services utilization in older adults with prior stroke. Neurology 2016;87(20):2091–2098.
   PubMedGoogle Scholar
• Ding R, et al. Comparison of health service use and costs in stroke with and without comorbidities: a cross-sectional analysis using China urban medical claims data. BMJ Open. 2020;10(12):e037032.
   PubMedGoogle Scholar
• Maruyama K, Uchiyama S, Iwata M. Metabolic syndrome and its components as risk factors for first-ever acute ischemic noncardioembolic stroke. J Stroke Cerebrovasc Dis. 2009;18(3):173–177.
   PubMedGoogle Scholar
• Zhao D, et al. Epidemiological transition of stroke in China: twenty-one-year observational study from the Sino-MONICA-Beijing Project. Stroke 2008;39(6):1668–1674.
   PubMed Web of Science ®Google Scholar
• Zhao Y, et al. Lifetime direct costs of stroke for indigenous patients adjusted for comorbidities. Neurology 2016;87(5):458–465.
   PubMedGoogle Scholar
• Elamy AH, et al. Common comorbidities of stroke in the Canadian population. Can J Neurol Sci. 2020;47(3):314–319.
   PubMed Web of Science ®Google Scholar
• Stratton IM, et al. Additive effects of glycaemia and blood pressure exposure on risk of complications in type 2 diabetes: a prospective observational study (UKPDS 75). Diabetologia. 2006;49(8):1761–1769.
   PubMed Web of Science ®Google Scholar
• Kokubo Y, et al. The combined impact of blood pressure category and glucose abnormality on the incidence of cardiovascular diseases in a Japanese urban cohort: the Suita Study. Hyperten Res. 2010;33(12):1238–1243.
   PubMedGoogle Scholar
• Sowers, JR. Diabetes mellitus and vascular disease. Hypertension. 2013;61(5):943–947.
   PubMedGoogle Scholar
• Chen G, et al. Cardiovascular outcomes in framingham participants with diabetes: the importance of blood pressure. Hypertension. 2011;57(5):891–897.
   PubMed Web of Science ®Google Scholar
• Komi R, et al. Burden of high blood pressure as a contributing factor to stroke in the Japanese community-based diabetic population. Hypertens Res. 2018;41(7):531–538.
   PubMedGoogle Scholar
• Han E, et al. Heterogeneity in costs and prognosis for acute ischemic stroke treatment by comorbidities. J Neurol. 2019;266(6):1429–1438.
   PubMedGoogle Scholar
• Iso H, et al. Serum total homocysteine concentrations and risk of stroke and its subtypes in Japanese. Circulation. 2004;109(22):2766–2772.
   PubMed Web of Science ®Google Scholar